guanylate cyclase C

临床试验

计划入组 23 人 · 首次发布于 2013 年 8 月 21 日

已完成

NCT02616861

Trial of IW-1973 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers

计划入组 54 人 · 首次发布于 2015 年 11 月 30 日

已完成

NCT02572349

Trial of IW-1701 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers

计划入组 24 人 · 首次发布于 2015 年 10 月 8 日

药物

查看全部 1764 →

Uroguanylin analog (DNIB Unwind/Synergy)

Small Molecule

Approved

Linaclotide(Constella, Linzess)

相关疾病：Functional Constipation (FC), Irritable Bowel Syndrome With Constipation (IBS-C)，另有 1 项

C₅₉H₇₉N₁₅O₂₁S₆ · Rx

ID-65-CW69

机构

查看全部 3022 →

C & C Oxygen Company

United States

Buchanan C Michael

United States

DENVER NEPHROLOGISTS P C

United States

资讯

查看全部 2361 →

去年

Real-World Safety Analysis Reveals New Adverse Events for Plecanatide Beyond Clinical Trial Data

去年

Dr. Reddy's Launches First-in-Class Linaclotide for Chronic Constipation in India

10个月前

临床试验

Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator

Trial of IW-1973 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers

Trial of IW-1701 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers

药物

Uroguanylin analog (DNIB Unwind/Synergy)

Linaclotide(Constella, Linzess)

ID-65-CW69

机构

C & C Oxygen Company

Buchanan C Michael

DENVER NEPHROLOGISTS P C

资讯

Real-World Safety Analysis Reveals New Adverse Events for Plecanatide Beyond Clinical Trial Data

Dr. Reddy's Launches First-in-Class Linaclotide for Chronic Constipation in India

FDA Approves First Pediatric Treatment for Irritable Bowel Syndrome with Constipation